Changes in Beneficial Ownership · 4
C4 Therapeutics, Inc.
CCCCNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
wk-form4_1782520384.xml
Filing details
- Report period
- 2026-06-24
- Issuer
- C4 Therapeutics, Inc.
- Issuer CIK
- 0001662579
- Trading symbol
- CCCC
Reporting owner 1
- Name
- Hughes Owen
- Reporting owner CIK
- 0001575933
- Relationship
- Director
- Address
- C/O C4 THERAPEUTICS, INC., 490 ARSENAL WAY #120, WATERTOWN, MA, 02472
Derivative transactions
| Security | Conversion / exercise price (USD) | Transaction date | Code | Amount | A / D | Price (USD) | Exercisable | Expires | Underlying security | Underlying shares | Owned after | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | 4.25 | 2026-06-24 | A · Form 4 | 62,000 | A | 0 | [F1] | 2036-06-23 | Common Stock | 62,000 | 62,000 | D |
Table key
- A · Form 4
- Acquisition by grant, award or otherwise under Rule 16b-3(d)
- A
- Acquired
- D
- Direct
Footnotes
- F1
- This option shall vest and become exercisable in full upon the earlier to occur of (i) June 24, 2027 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date.↩ 1
Signature 1
- Signed
- /s/ Shagha Russell, Attorney-in-Fact
- Date
- 2026-06-26
Recent company filings
- 10-Q filingNov 5, 2026
- Results of Operations and Financial ConditionNov 5, 2026
- Regulation FD Disclosure · Other EventsSep 25, 2026
- SCHEDULE 13G/A - filed by Lynx1 Capital Management LP regarding C4 Therapeutics, Inc.Aug 14, 2026
- SCHEDULE 13G/A - filed by Squadron Capital Management LLC regarding C4 Therapeutics, Inc.Aug 14, 2026